Clinical Trial Update: Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating naltrexone initiation in adults with opioid use disorder before the first dose of VIVITROL extended-release naltrexone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opioid Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-01-09